The Role of MT1/ MT2 Melatonin Membrane Receptors in Mediating the Neuroprotective Effects of Melatonin in Alzheimer's Disease
Alzheimer's disease (AD) currently underlies dementia for tens of millions of people worldwide, and its occurrence is set to double in the next 20 years. The currently approved drugs for treating AD only marginally ameliorate cognitive deficits, and provide limited symptomatic relief, while new...
Other Authors: | O'Neal-Moffitt, Gina (authoraut) |
---|---|
Format: | Others |
Language: | English English |
Published: |
Florida State University
|
Subjects: | |
Online Access: | http://purl.flvc.org/fsu/fd/FSU_migr_etd-9067 |
Similar Items
-
Pineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer’s disease
by: P Brunner, et al.
Published: (2009-06-01) -
MT1 melatonin receptors and their role in the oncostatic action of melatonin
by: Karolina Danielczyk, et al.
Published: (2009-09-01) -
Melatonin MT1 and MT2 Receptors in the Ram Reproductive Tract
by: Marta González-Arto, et al.
Published: (2017-03-01) -
Human gastroenteropancreatic expression of melatonin and its receptors MT1 and MT2.
by: Fanny Söderquist, et al.
Published: (2015-01-01) -
New Radioligands for Describing the Molecular Pharmacology of MT1 and MT2 Melatonin Receptors
by: Olivier Nosjean, et al.
Published: (2013-04-01)